In July 2017 the Legislative and Governance Forum on Gene Technology (the Forum) formally commenced the Third Review (Third Review) of the National Gene Technology Scheme (the Scheme). The initial aim of the Review was to assess the operation of the Scheme with respect to its policy objectives. The Review also sought to identify areas where changes might assist to future-proof and modernise the Scheme, to help ensure efficiency and timeliness of the responses to emerging technologies....More
Consultation on the recently released Issues Paper – Implementing Recommendations of the Third Review of the Gene Technology Scheme: Phase 1 Consultation (the Issues Paper), is now open. To obtain a copy of the Issues Paper, please refer to the hyperlinks below.
Recognising the importance of ongoing consultation to inform implementation of the recommendations arising from the Third Review of the National Gene Technology Scheme (the Review), an Issues Paper to inform three key priority...More
Phase 3 consultation has now closed.
In recognising the importance of thorough consultation to inform this Review, consultation has been organised in three key phases:
Phase 1: identifying key issues for consideration (completed)
Phase 2: collaboratively exploring policy solutions to these issues (completed)
Phase 3: Preliminary Report (completed)
Phase 1 and 2 consultations included almost 160 written and online submissions, eleven face-to-face consultation...More
The first stage of consultation closed on 29 September 2017.
The Legislative and Governance Forum on Gene Technology (the Forum) thanks all that have provided submissions.
The Forum, also known as the LGFGT, is responsible for overseeing and governing the operation of the Scheme. The Forum is established by an intergovernmental Gene Technology Agreement (GTA) and includes Ministers from the Commonwealth and all States and Territories across a range of portfolios including health,...More